Published on 29 Dec 2023 on GuruFocus.com via Yahoo Finance
Director Wendall Wierenga Sells 10,000 Shares of Cytokinetics Inc (CYTK)
On December 27, 2023, Wendall Wierenga, a director at Cytokinetics Inc (NASDAQ:CYTK), sold 10,000 shares of the company's stock, according to a recent SEC Filing. Cytokinetics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining.
Warning! GuruFocus has detected 9 Warning Signs with CYTK.
Over the past year, the insider has sold a total of 23,020 shares and has not made any purchases of the company's stock.